Medical Equipment

Global Platelet Aggregation Devices Market Revenue and Share Analysis Through 2029

December 8, 2025 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the platelet aggregation devices market from 2025–2034 with trusted insights from The Business Research Company

What Is The Projected Valuation Of The Platelet Aggregation Devices Market In The Period 2029-2034?

The market for platelet aggregation devices has experienced rapid expansion over recent years. It is anticipated to expand from $0.83 billion in 2024 to $1.04 billion in 2025, with a compound annual growth rate (CAGR) of 24.9%. The historical growth of this market can be attributed to factors such as the increasing prevalence of cardiovascular diseases, a rise in the incidence of bleeding disorders, growing awareness about health diagnostics, an increase in surgical procedures, and improved diagnostic accuracy.

The platelet aggregation devices market is set for significant expansion over the next few years. It is predicted to reach $2.46 billion by 2029, growing at a compound annual growth rate (CAGR) of 23.9%. This projected increase during the forecast period is largely driven by a demographic shift towards an older population, an increasing demand for point-of-care testing, the wider adoption of personalized medicine, supportive regulatory environments and approvals, and a rising prevalence of chronic health conditions. Notable developments anticipated in this period include the incorporation of artificial intelligence into diagnostic tools, the creation of portable platelet aggregation devices, enhanced collaborations between biotechnology firms and healthcare providers, the growing importance of data analytics in healthcare, and a shift towards diagnostic solutions for home use.

Access A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=15896&type=smp

What Strategic Drivers Are Accelerating The Platelet Aggregation Devices Market Expansion?

The platelet aggregation devices market is anticipated to expand due to the rising occurrence of target diseases. These target diseases refer to particular medical conditions, such as cancer, cardiovascular diseases, and diabetes, which are prioritized for prevention, diagnosis, and treatment owing to their significant public health impact. Platelet aggregation devices contribute to reducing the prevalence of these target diseases by facilitating prompt detection and efficient management of thrombotic risks, thereby averting severe complications like heart attacks and strokes in at-risk groups. As an illustration, figures released in February 2024 by the International Agency for Research on Cancer (IARC), a France-based specialized cancer agency of the World Health Organization (WHO), revealed around 20 million new cancer cases and 9.7 million deaths globally in 2022. Forecasts suggest a 77% surge, leading to over 35 million new cases by 2050. Lung cancer emerged as the most widespread worldwide with 2.5 million new cases (12.4%), followed by female breast cancer (2.3 million cases, 11.6%), colorectal cancer (1.9 million cases, 9.6%), prostate cancer (1.5 million, 7.3%), and stomach cancer (970,000, 4.9%). Consequently, the increasing incidence of target diseases is fueling the expansion of the platelet aggregation devices market.

What Is The Detailed Segment Distribution Of The Platelet Aggregation Devices Market?

The platelet aggregation devicesmarket covered in this report is segmented –

1) By Product: Reagents, Systems, Consumables And Accessories

2) By Type: Four Channel, Dual Channel, Eight Channel

3) By Technology: Optical, Impedance, Other Technologies

4) By Application: Clinical Applications, Research Applications, Cardiovascular Applications, Orthopedic Applications, Other Applications

5) By End-User: Standalone Hospitals, Diagnostic Laboratories, Research And Academic Institutes, Other End Users

Subsegments:

1) By Reagents: Platelet Aggregation Assay Reagents, Coagulation And Anticoagulation Reagents

2) By Systems: Platelet Aggregation Testing Systems, Automated Platelet Aggregation Systems

3) By Consumables And Accessories: Sample Collection Kits, Testing Plates And Cuvettes, Calibration Kits

Which Market Trends Are Expected To Define The Future Of The Platelet Aggregation Devices Market?

Companies operating in the platelet aggregation devices market are intensifying their efforts to develop sophisticated solutions, introducing innovative products like the first platelet pooling set aimed at stabilizing the U.S. platelet supply and fulfilling growing requirements. A platelet pooling set is a specialized medical instrument employed during plateletpheresis procedures to collect and concentrate platelets from multiple donors into one unit for transfusion therapy. For instance, in February 2023, TERUMO BCT INC., a US-based company specializing in blood components and cellular technology, announced the Food and Drug Administration (FDA), a US-based federal agency, had approved the IMUGARD WB Platelet Pooling Set. This product offers an extended shelf life for platelets, FDA clearance for seven-day storage, and enables platelet recoupment from whole blood donations, thereby enhancing flexibility and availability within the platelet aggregation devices market. This launch marks a significant technological advancement by addressing the need for improved platelet availability, more efficient supply management, and supporting the strained U.S. platelet supply to meet increasing demand in crucial medical procedures such as chemotherapy and organ transplants.

Who Are The Major Stakeholders Operating In The Platelet Aggregation Devices Market?

Major companies operating in the platelet aggregation devices market are Roche Holding AG, Cytiva (Danaher Corp.), Siemens Healthineers, Sysmex Corporation, WerfenLife S.A., Haemonetics Corporation, Helena Laboratories Corporation, Sarstedt AG & Co. KG, Sekisui Diagnostics LLC, Diagnostica Stago, Accriva Diagnostics Holdings Inc., Drucker Diagnostics, Sentinel CH. SpA, ADInstruments, Chrono-Log Corporation, Bio/Data Corporation, Haemochrom Diagnostica GmbH, AggreDyne Inc., Hart Biologicals Ltd., Stago

Download The Full Report Here:

https://www.thebusinessresearchcompany.com/report/platelet-aggregation-devices-global-market-report

Which Region Is Projected To Achieve The Fastest Growth In The Platelet Aggregation Devices Market?

North America was the largest region in the platelet aggregation devices market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the platelet aggregation devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Get A Report Customized For You Here:

https://www.thebusinessresearchcompany.com/customise?id=15896&type=smp

Browse Through More Reports Similar to the Global Platelet Aggregation Devices Market 2025, By The Business Research Company

Platelet Shaker Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/platelet-shaker-global-market-report

Blood Preparation Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/blood-preparation-global-market-report

Blood Pressure Monitoring Devices Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/blood-pressure-monitoring-devices-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795